10 ML crizanlizumab-tmca 10 MG/ML Injection [Adakveo]
- RxCUI
- 2262430
- RxNorm name
- 10 ML crizanlizumab-tmca 10 MG/ML Injection [Adakveo]
- Display name
- 10 ML crizanlizumab-tmca 10 MG/ML Injection [Adakveo]
- Full name
- 10 ML crizanlizumab-tmca 10 MG/ML Injection [Adakveo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761128 | Adakveo | crizanlizumab-tmca | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADAKVEO | CRIZANLIZUMAB | Novartis Pharmaceuticals Corporation | b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6 | 2026-06-04 | Warnings, Adverse reactions | 2262430 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b2b7f8b4-fe9a-4a86-8129-9e43f99a20c6 | ADAKVEO 100 MG in 10 ML Injection [PSN] · 10 ML crizanlizumab-tmca 10 MG/ML Injection [Adakveo] [SBD] · Adakveo 10 MG/ML per 10 ML Injection [SY] · Adakveo 100 MG per 10 ML Injection [SY] | 4 | 7 | These highlights do not include all the information needed to use ADAKVEO safely and effectively. See full prescribing information for ADAKVEO. ADAKVEO ® (crizanlizumab-tmca) injection, for intravenous use Initial U.S. Approval: 2019 | 20250603 |